Erythropoietin receptor expression is a potential prognostic factor in human lung adenocarcinoma.

Erythropoietin receptor expression is a potential prognostic factor in human lung adenocarcinoma.

Recombinant human erythropoietins (rHuEPOs) are used to treat cancer-related anemia. Recent preclinical studies and clinical trials, however, have raised concerns about the potential tumor-promoting effects of these drugs. Because the clinical significance of erythropoietin receptor (EPOR) signaling...

Full description

Bibliographic Details
Main Authors: Anita Rózsás, Judit Berta, Lívia Rojkó, László Z Horváth, Magdolna Keszthelyi, István Kenessey, Viktória László, Walter Berger, Michael Grusch, Mir Alireza Hoda, Szilvia Török, Walter Klepetko, Ferenc Rényi-Vámos, Balázs Hegedűs, Balázs Döme, József Tóvári
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3796497?pdf=render

Internet

http://europepmc.org/articles/PMC3796497?pdf=render

Similar Items